Article

Molecular profiling in HNSCC patients targets potential responsiveness to ICIs

2022-12-16

Abstract excerpt

Immunotherapy is emerging as a valid therapeutic strategy for various cancers although only a subset of patients responding to the therapy. The response to immunotherapy remains low for many cancer types because of poor ability to appropriately classify responding patients. We analyzed TCGA cohort of HNSCC patients in relation to a 26 immune gene set and cell types to define signaling pathways associated with resi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8923dbd7-ed64-5744-af15-ca6a11ad64e1
DOI: 10.1101/2022.12.16.520703

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Molecular profiling in HNSCC patients targets potential responsiveness to ICIsDOI 10.1101/2022.12.16.520703Read

TP53 mutation-associated immunosignatures impact on anti-PD-L1 treatment response in head and neck cancer patients.Semantic proximity Read

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patientsSemantic proximity Read

Integrating Immune Multi-Omics and Machine Learning to Improve Prognosis, Immune Landscape, and Sensitivity to First- and Second-Line Treatments for Head and Neck Squamous Cell CarcinomaSemantic proximity Read

Identification of Immune-related lncRNA Panel for Predicting Immune Checkpoint Blockade and Prognosis in Head and Neck Squamous Cell CarcinomaSemantic proximity Read

Why responses to immune checkpoint inhibitors are heterogeneous in head and neck cancers: Contributions from tumor-intrinsic and host-intrinsic factorsSemantic proximity Read

A DNA damage repair signature predicted immunotherapy response and clinical prognosis in HNSCCSemantic proximity Read

Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell CancerSemantic proximity Read

Subtyping of head and neck squamous cell cancers based on immune signatures.Semantic proximity Read

Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma.Semantic proximity Read

Immune related gene signature derived from integrate machine learning algorithm predicts outcomes of HNSC patientsSemantic proximity Read

Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma.Semantic proximity Read

A 25-gene panel predicting the benefits of immunotherapy in head and neck squamous cell carcinoma.Semantic proximity Read